Authors:
GOLDHIRSCH A
GELBER RD
PRICE KN
CASTIGLIONE M
COATES AS
RUDENSTAM CM
COLLINS J
LINDTNER J
HACKING A
MARINI G
BYRNE M
CORTESFUNES H
SCHNURCH G
BRUNNER KW
TATTERSALL MHN
FORBES J
SENN HJ
Citation: A. Goldhirsch et al., EFFECT OF SYSTEMIC ADJUVANT TREATMENT ON FIRST SITES OF BREAST-CANCERRELAPSE, Lancet, 343(8894), 1994, pp. 377-381
Citation: Kw. Brunner, PRIMUM NIL NOCERE AND CLINICAL CANCER-RES EARCH - THOUGHTS ON A CONTROVERSY, Schweizerische medizinische Wochenschrift, 124(43), 1994, pp. 1885-1886
Authors:
GOLDHIRSCH A
GELBER RD
CASTIGLIONE M
PRICE KN
RUDENSTAM CM
LINDTNER J
COLLINS J
SENN HJ
BRUNNER KW
GALLIGIONI E
CAVALLI F
GUDGEON A
CORTESFUNES H
TATTERSALL M
MARINI G
BYRNE M
SNYDER R
FORBES JF
HURNY C
COATES A
Citation: A. Goldhirsch et al., PRESENT AND FUTURE PROJECTS OF THE INTERNATIONAL BREAST-CANCER STUDY-GROUP, Cancer, 74(3), 1994, pp. 1139-1149
Authors:
BUSER KS
JOSS RA
PIQUET D
AAPRO MS
CAVALLI F
HAEFLIGER JM
JUNGI WF
BAUER J
OBRIST R
BRUNNER KW
WEBER T
VERITY L
BUTCHER M
Citation: Ks. Buser et al., ORAL ONDANSETRON IN THE PROPHYLAXIS OF NAUSEA AND VOMITING INDUCED BYCYCLOPHOSPHAMIDE, METHOTREXATE AND 5-FLUOROURACIL (CMF) IN WOMEN WITHBREAST-CANCER - RESULTS OF A PROSPECTIVE, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY, Annals of oncology, 4(6), 1993, pp. 475-479